Locations
Baltimore, MD, USA · Baltimore, MD, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2019
Delfi Diagnostics is a pioneering company focused on early cancer detection through advanced machine learning and fragmentomics technology. Their innovative approach utilizes liquid biopsy blood samples to analyze cell-free DNA fragments, enabling the identification of previously unrecognized cancer-associated patterns. With a commitment to making cancer screening widely accessible, DELFI aims to serve high-risk populations by providing affordable and effective testing solutions. The company has enrolled thousands of participants in its clinical trials, demonstrating significant traction in the market and positioning itself as a leader in the field of non-invasive cancer diagnostics.
Is this your company?
Something looks off?
On-site & Remote